| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6150974 | Contemporary Clinical Trials | 2015 | 6 Pages |
Abstract
With participation of 4184 families and more than 93% adherence to clinical follow-up at 3 and 13Â months, this randomised clinical trial has the potential to create evidence regarding non-specific effects of BCG vaccination in a high-income setting.
Keywords
E. coliDSMBASQSCORADMMRIFN-γSSIBCGPHAIgEe-CRFLPSBacillus Calmette-GuérinNon-specific effects of vaccinesCPRStreptococcus pneumoniaeEscherichia coliData safety and monitoring boardHeterologous immunity IgE, immunoglobulin Einterleukintumor necrosis factor alphaScoring Atopic Dermatitiscentimetremeasles, mumps, rubellaTNF-αElectronic case report formlipopolysaccharidePneumococcal conjugate vaccinePentavalent vaccineBCG vaccinationAges and Stages QuestionnaireRandomised clinical trialCandida albicansChildrenInterferon gammagrams
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Lisbeth Marianne Thøstesen, Thomas Nørrelykke Nissen, Jesper Kjærgaard, Gitte Thybo Pihl, Nina Marie Birk, Christine Stabell Benn, Gorm Greisen, Poul-Erik Kofoed, Ole Pryds, Henrik Ravn, Dorthe Lisbeth Jeppesen, Peter Aaby, Lone Graff Stensballe,